We dont know what we dont know. So to think that we have laid out a complete process to protect policy holders from this new underwriting information is dangerous.
Insurance companies will use the information and the knowledge of the availability of the information to underwrite and price risk. In the long run, this will lower the cost of risk for some and raise the cost for others.
It is naïve to think the information will not be used negatively by some insurers. Insurers are already using information regarding the prescriptions taken by an individual to adjust the rates for that person. Why would we think genetic information would be any different? Insurers are also already collecting blood samples from many policyholders.
I provide the above as some food for thought.
Dennis KellyRockville, Md.
Comment on todays news or other matters. Submit your comments to the Daily Dialogue at [email protected]. Submissions must include name, title, affiliation, city and state. Modern Healthcare reserves the right to edit all submissions.